26th May 2006 07:00
26 May 2006 Medical Solutions plc ("Medical Solutions") Medical Solutions announces addition of Circulating Tumour Cell ("CTC") technology to its reference laboratory product portfolio Wins new CTC agreement Medical Solutions, the provider of pathology and cytology products and servicesto the healthcare and pharmaceuticals sector, announces that it has acquiredthe CellTracks Analyser II and CellTracks AutoPrep Systems, manufactured byImmunicon Corporation and both supplied by Veridex LLC in Europe, to enhanceits reference laboratory product portfolio.These systems are designed to identify and quantify the presence of cancerouscells in the peripheral blood system, known as Circulating Tumour Cells("CTC's") with a high degree of sensitivity and specificity and in an automatedand standardised manner. The presence of CTC's in blood is associated with alower survival rate in patients being treated for metastatic breast cancer.Medical Solutions is the only UK commercial reference laboratory providing CTCanalysis although there are several such centres in the United States.Medical Solutions also announces that it has entered into an agreement with anunnamed multinational pharmaceutical company to provide CTC analysis in supportof a clinical trial currently being conducted. Terms of the contract were notdisclosed. -ends- For further information:Medical SolutionsCharles Green/Neil Johnston 0115 973 9010Bell PottingerGeoff Callow/Chris Hamilton 020 7861 3232Notes to EditorMedical Solutions is an international healthcare business, providing specialistdiagnostic pathology and cytology services and products to the healthcare andpharma/biotech sectors. The Group employs advanced technology in image analysisand high throughput quantitative protein expression and biomarker determinationfrom its state of the art reference laboratories in the UK.ENDMEDICAL SOLUTIONS PLCRelated Shares:
SBS.L